Is Clostridium difficile infection influenced by antimicrobial use density in wards?
This study was performed to elucidate the relationship between antimicrobial use density (AUD) and Clostridium difficile infection (CDI) manifesting as antimicrobial-associated diarrhea (AAD) in hospital wards during a 4-year period. Case definition of CDI was an adult exhibiting AAD with a daily stool frequency of three or more, arising at least 48 hours after ward admission, and fecal samples testing positive for toxin (A and/or B). Metronidazole or vancomycin was orally administered as treatment. AUDs were calculated for a total of 21 antimicrobials in a span of 48 months and nine wards. We included the average value of AUDs, representing two succeeding months of sample submission into the sample information. We also entered data on the 2-year division and intensified contact precaution for statistical analysis. Of a total of 463 cases, 95 (20.5%) were CDI-positive. Multivariate regression analysis showed odds ratios [OR] of 1.739 (95% confidence interval [CI] of 1.050 - 2.881, P = 0.032) and 1.598 (95% CI of 1.006 -2.539, P = 0.047) for clindamycin and piperacillin, respectively in AUD. Thus increased ward AUDs of clindamycin and piperacillin may run the risk of CDI.
Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.
Nobumichi
N
Ogami
Junichi
J
Yoshida
Toshiyuki
T
Ishimaru
Tetsuya
T
Kikuchi
Nobuo
N
Matsubara
Takako
T
Ueno
Ikuyo
I
Asano
D000890:Anti-Infective Agents / Q000009:adverse effects*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000139:chemically induced*; D003967:Diarrhea / Q000139:chemically induced*; D006801:Humans; D016015:Logistic Models; D012306:Risk
D000890:Anti-Infective Agents